Key clinical point: The drop in the invasive melanoma incidence decreased in adolescents and young adults, but incidence increased among older adults between 2006 and 2015.
Major finding: The annual percentage change in melanoma incidence between 2006 and 2015 dropped by 4.4% for male adolescents, 5.4% for female adolescents, 3.7% for male young adults, and 3.6% for female young adults.
Study details: The data come from a population-based analysis of 988,103 cases of invasive melanoma in the United States between 2001 and 2015.
Disclosures: The study was supported in part by the National Institutes of Health, the Fred Hutchinson Cancer Research Center Integrated Immunotherapy Research Core, and a Society for Immunotherapy of Cancer–Merck fellowship. Dr. Paulson disclosed grants from the Society for Immunotherapy of Cancer–Merck, bluebird biosciences, and EMD Serono. She also disclosed an issued and licensed patent for a Merkel cell carcinoma T cell receptor.
Paulson KG et al. JAMA Dermatol. 2019. Nov 13. doi: 10.1001/jamadermatol.2019.3353.